Lifevantage Corp (LFVN) Latest Filing Signal

Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, Lifevantage Corp's filing signal turned negative.

LifeVantage Corporation operates as a direct-to-consumer company specializing in nutrigenomics, focusing on products that support health through the study of nutrition and genes. The company markets a range of scientifically validated dietary supplements, weight management products, skin and hair care items, and nootropics under brands like Protandim(R), LifeVantage(R), TrueScience(R), PhysIQTM, Petandim(R), and AXIO(R). LifeVantage utilizes a network marketing model, relying on independent consultants to sell its products across 18 countries, with the United States and Japan being its primary markets. The company emphasizes its "activating wellness" message, leveraging technology and a proprietary compensation plan to motivate its consultant base and drive sales.

Revenue is primarily driven by the sale of its Protandim(R), LifeVantage(R), and TrueScience(R) product lines, which accounted for approximately 87.6% of total revenue in fiscal year 2025. The company's success is also dependent on the effectiveness of its network of independent consultants in attracting and retaining customers.